<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present a patient with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e>, as defined by nine pregnancy losses, the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LAC), and the absence of clinical signs and symptoms of <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A successful pregnancy was achieved by treatment with low-dose <z:chebi fb="0" ids="8382">prednisone</z:chebi> (15 mg daily) and aspirin (100 mg daily) </plain></SENT>
<SENT sid="2" pm="."><plain>The patient was followed-up throughout her two last pregnancies and a 6 months postpartum period </plain></SENT>
<SENT sid="3" pm="."><plain>Our data indicate that LAC serves as a marker of disease in women with previous pregnancy wastages, and that aspirin-<z:chebi fb="0" ids="8382">prednisone</z:chebi> therapy is beneficial in carefully selected patients </plain></SENT>
</text></document>